BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 26723577)

  • 1. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.
    Bougioukli S; Jain A; Sugiyama O; Tinsley BA; Tang AH; Tan MH; Adams DJ; Kostenuik PJ; Lieberman JR
    Bone; 2016 Mar; 84():93-103. PubMed ID: 26723577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model.
    Tinsley BA; Dukas A; Pensak MJ; Adams DJ; Tang AH; Ominsky MS; Ke HZ; Lieberman JR
    J Bone Joint Surg Am; 2015 Nov; 97(22):1852-9. PubMed ID: 26582615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption.
    Kim RY; Oh JH; Lee BS; Seo YK; Hwang SJ; Kim IS
    Biomaterials; 2014 Feb; 35(6):1869-81. PubMed ID: 24321706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.
    Wutzl A; Brozek W; Lernbass I; Rauner M; Hofbauer G; Schopper C; Watzinger F; Peterlik M; Pietschmann P
    J Biomed Mater Res A; 2006 Apr; 77(1):75-83. PubMed ID: 16355411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP-2-transduced human bone marrow stem cells enhance neo-bone formation in a rat critical-sized femur defect.
    Müller CW; Hildebrandt K; Gerich T; Krettek C; van Griensven M; Rosado Balmayor E
    J Tissue Eng Regen Med; 2017 Apr; 11(4):1122-1131. PubMed ID: 25783748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of recombinant human bone morphogenetic protein-2 and -9 on bone formation in rat calvarial critical-size defects.
    Nakamura T; Shirakata Y; Shinohara Y; Miron RJ; Hasegawa-Nakamura K; Fujioka-Kobayashi M; Noguchi K
    Clin Oral Investig; 2017 Dec; 21(9):2671-2679. PubMed ID: 28197731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft.
    Krishnan L; Priddy LB; Esancy C; Li MT; Stevens HY; Jiang X; Tran L; Rowe DW; Guldberg RE
    Clin Orthop Relat Res; 2015 Sep; 473(9):2885-97. PubMed ID: 25917422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP-silk composite matrices heal critically sized femoral defects.
    Kirker-Head C; Karageorgiou V; Hofmann S; Fajardo R; Betz O; Merkle HP; Hilbe M; von Rechenberg B; McCool J; Abrahamsen L; Nazarian A; Cory E; Curtis M; Kaplan D; Meinel L
    Bone; 2007 Aug; 41(2):247-55. PubMed ID: 17553763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.
    de Molon RS; Shimamoto H; Bezouglaia O; Pirih FQ; Dry SM; Kostenuik P; Boyce RW; Dwyer D; Aghaloo TL; Tetradis S
    J Bone Miner Res; 2015 Sep; 30(9):1627-40. PubMed ID: 25727550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats.
    Hsu WK; Sugiyama O; Park SH; Conduah A; Feeley BT; Liu NQ; Krenek L; Virk MS; An DS; Chen IS; Lieberman JR
    Bone; 2007 Apr; 40(4):931-8. PubMed ID: 17236835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone repair of critical size defects treated with autogenic, allogenic, or xenogenic bone grafts alone or in combination with rhBMP-2.
    Issa JP; Gonzaga M; Kotake BG; de Lucia C; Ervolino E; Iyomasa M
    Clin Oral Implants Res; 2016 May; 27(5):558-66. PubMed ID: 26260954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
    Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
    Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
    Jin Q; Cirelli JA; Park CH; Sugai JV; Taba M; Kostenuik PJ; Giannobile WV
    J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model.
    Kodera R; Miyazaki M; Yoshiiwa T; Kawano M; Kaku N; Tsumura H
    Bone; 2014 Jan; 58():26-32. PubMed ID: 24103577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
    Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
    Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery vehicle effects on bone regeneration and heterotopic ossification induced by high dose BMP-2.
    Krishnan L; Priddy LB; Esancy C; Klosterhoff BS; Stevens HY; Tran L; Guldberg RE
    Acta Biomater; 2017 Feb; 49():101-112. PubMed ID: 27940197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model.
    Doi Y; Miyazaki M; Yoshiiwa T; Hara K; Kataoka M; Tsumura H
    Bone; 2011 Oct; 49(4):777-82. PubMed ID: 21777711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of osteogenic cell differentiation in response to bone morphogenetic protein or demineralized bone matrix in a critical sized defect model using GFP reporter mice.
    Alaee F; Hong SH; Dukas AG; Pensak MJ; Rowe DW; Lieberman JR
    J Orthop Res; 2014 Sep; 32(9):1120-8. PubMed ID: 24888702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of caffeine and/or estrogen deficiency on trabecular bone area and healing: a study in rats.
    Bastos MF; Menezes DJ; Bezerra JP; Braz CK; Fonseca PF; Arana-Chavez VE; Azambuja N; Duarte PM
    Int J Oral Maxillofac Implants; 2014; 29(1):221-31. PubMed ID: 24451874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.